Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stocks Crossing The 13 Week Moving Average <$10.01 -- Ignore unavailable to you. Want to Upgrade?

To: James Strauss who wrote (4577)	6/29/1999 10:42:00 PM
From: Mao II	Read Replies (2) \| Respond to of 13094

Herr Doktor! What do U read in the immediate future of TRID, which has moved nicely in recent times, but is now basing a bit on lowish vol. (Actually, Im discounting the volume issue a bit, due to flacid vol all around.) M2

To: James Strauss who wrote (4577)	7/1/1999 2:04:00 AM
From: Jibacoa	Read Replies (1) \| Respond to of 13094

JIM: ELOT: Moving well today. SOMN: Good move today.Company reportedly has $2 per share in cash and no debt: For the first quarter of 1999, Somnus reported net revenues of $2.3 million compared to net revenues of $1.7 million for the first quarter of 1998. The net loss for the first quarter of 1999 was $4.1 million, or $0.29 per share, compared to a net loss of $4.1 million, or $0.30 per share, in the first quarter of 1998. As of March 31, 1999, Somnus had cash and cash equivalents of $30 million, total assets of $34 million and no long-term debt. There are quite a few people with "problem snoring" and a few "Pickwickian" with "sleep apnea". I am not sure they have full FDA approval. I will check with some ENT friends. Bernard.